Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973349 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
A Phase 2 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,719
- Enrollment target
NCT00973349: Completed Phase 2 study, sponsored by Novartis.
NCT00973349 is a Phase 2 study that has completed, run by Novartis. The registered enrollment target is 2,719 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1944% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00973349, a Phase 2 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,719 participants
- Enrollment target
Study Summary
This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in non-elderly and elderly adults.
Primary Outcome
Seroconversion is defined by CBER (Center for Biologics Evaluation, Research and Review) as the percentage of participants with either a prevaccination HI titer \<1:10 and a post vaccination HI titer \> 40 or a pre-vaccination HI titer \> 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.
Interventions
- BIOLOGICAL MF59-eH1N1_f
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,719 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
What the finished NCT00973349 record still lists
NCT00973349 is an interventional study that assigns participants to a tested intervention. Its 2,719 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1944% higher).
The record links to 0 conditions, and to 1 intervention - of which MF59-eH1N1_f is the first listed.
NCT00973349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00973349 about?
NCT00973349 is a clinical study titled "Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults". This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in non-elderly and elderly adults.
What is the current status of trial NCT00973349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,719 participants. The study started on 2009-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00973349?
The interventions under investigation include: MF59-eH1N1_f (BIOLOGICAL).
Who is sponsoring clinical trial NCT00973349?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00973349's enrollment target sits among peer trials
2,719 7th of 2000 higher than 1,994 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06085833 · 2,706 participants · NA
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia